Alnylam Pharmaceuticals, Inc. (ALNY) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Alnylam Pharmaceuticals, Inc. (ALNY)

ALNY 456.04

+1.4%

Oct 31 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: RadMan55 who wrote (98)	1/10/2007 12:30:12 AM
From: tuck	Read Replies (2) of 166

Worth caps and two exclamation points, eh? You must be very excited. Do you own one or the other? Probably -- and hopefully -- Inex. Though not that much money and somewhat back-end loaded for Inex. And no royalties at all? Still, not bad considering a) it's just a delivery technology, and b) they got some IP out of ALNY, as well. I'm guessing that at the levels ALNY at which is trading, ALNY will give Inex $4 million in ALNY stock. I actually consider ALNY to be something of a short candidate at these levels. Too much of its recent rise came from nothing other than the "validation" of the RNAi sector granted by the munch of Sirna, IMO. I like the company, but I think it's valued pretty richly given the maturity of their programs and the murkiness of IP in the RNAi sector. No position at the moment, but had one a few weeks ago -- which worked -- and looking for another entry. Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next